glp 1 agonist mechanism of action weight loss GLP-1 Agonists For Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH Glucagon-Like Peptide 1 Receptor Agonists

(2024) A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings

[6] Diabetes statistics Diabetes is a chronic disease, characterised by a persons body not being able to produce or utilize insulin adequately enough to absorb glucose from the bloodstream

2015, Smith et al

GLP-1s like Wegovy and Mounjaro have four mechanisms to improve blood sugar levels and support weight loss: Improve insulin function: Improving insulin response to glucose from meals enables the body to move glucose from the blood and into the cells (like muscle cells) to be burnt for energy or stored as glycogen